Cargando…
Modeling of α/β for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer
BACKGROUND: Recently, the use of hypo-fractionated treatment schemes for the prostate cancer has been encouraged due to the fact that α/β ratio for prostate cancer should be low. However a major concern on the use of hypofractionation is the late rectal toxicity, it is important to be able to predic...
Autores principales: | Marzi, Simona, Saracino, Biancamaria, Petrongari, Maria G, Arcangeli, Stefano, Gomellini, Sara, Arcangeli, Giorgio, Benassi, Marcello, Landoni, Valeria |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733302/ https://www.ncbi.nlm.nih.gov/pubmed/19689825 http://dx.doi.org/10.1186/1756-9966-28-117 |
Ejemplares similares
-
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control
por: Petrongari, Maria Grazia, et al.
Publicado: (2013) -
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control
por: Saracino, Biancamaria, et al.
Publicado: (2014) -
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
por: Sanguineti, Giuseppe, et al.
Publicado: (2019) -
Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound
por: Landoni, Valeria, et al.
Publicado: (2013) -
Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)